SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Greg Spendjian who wrote (598)9/15/1997 11:58:00 PM
From: Done, gone.   of 14101
 
Greg,

Re. Thailand WF-10 approval newsrelease.

My favorite part:

"The approval is based upon favourable results from seven years of clinical investigations in open label studies with immune compromised patients using WF10. In a presentation at an international workshop on immune modulation in May 1997, Dr. S. Tansuphaswadikul, principal investigator in an open study conducted with HIV positive patients, stated "after six years of follow up, 89% of patients enrolled in this study who had not yet progressed to the final stage of HIV disease, were long-term non-progressors and did not develop severe opportunistic infections or malignancies." Dr.
Kuhne added, "WF10 has proven to be an exceptionally safe drug."

Bounced Czech
(Who? Me? Excited? We knew all that, but the rest of the world?)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News